Luca Pasquini

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Viruses

Journal of clinical medicine

Autophagy

Medicines (Basel, Switzerland)

Istituto Superiore di Sanità

Università degli Studi di Roma La Sapienza (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Superiore di Sanità

Italy

Researcher :: Core Facilities

Istituto Superiore di Sanità Nov 10 2003 - Jul 07 2016

Italy

Contract Researcher :: Hematology, Oncology and Molecular Medicine

Education History

Università degli Studi di Roma La Sapienza

Italy

PHD

Publications

Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses 16 (1) (2024)
Germana Castelli, Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Annamaria Cerio, Vincenza Dolo, Luca Pasquini, Maria Screnci, Tiziana Ottone, Ugo Testa, Stefano Fais, Elvira Pelosi
Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming-The Potential Role of Ascorbic Acid. International journal of molecular sciences 24 (21) (2023)
Valeria Coppola, Ilaria Marino, Uwe Warnken, Mario Falchi, Luca Pasquini, Mauro Biffoni, Ruggero De Maria, Tobias Longin Haas
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8). Autophagy (2023)
Lucia Lisa Petrilli, Federica Riccio, Giulio Giuliani, Alessandro Palma, Cesare Gargioli, Simone Vumbaca, Monika Faron, Graziana Palmieri, Luca Pasquini, Francesca Sacco, Gianni Cesareni, Luisa Castagnoli, Claudia Fuoco
Skeletal Muscle Subpopulation Rearrangements upon Rhabdomyosarcoma Development through Single-Cell Mass Cytometry. Journal of clinical medicine 10 (4) (2021)
Ugo Testa, Eleonora Petrucci, Luca Pasquini
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines (Basel, Switzerland) 5 (1) (2018)

Luca Pasquini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luca Pasquini